{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:03:57Z","timestamp":1793685837784,"version":"4.5.1"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.pharmthera.2023.108456","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T01:55:06Z","timestamp":1685152506000},"page":"108456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease"],"prefix":"10.1016","volume":"248","author":[{"given":"Roc\u00edo","family":"Rivera Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy James","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108456_bb0005","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108456_bib836","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ecco-jcc\/jjac030","article-title":"Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-Term Extension","volume":"16","author":"Abreu","year":"2022","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0010","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.3748\/wjg.v24.i36.4093","article-title":"Interleukin 12\/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn\u2019s disease","volume":"24","author":"Aggeletopoulou","year":"2018","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/08820139.2016.1168830","article-title":"Suppression of MAPKs\/NF-\u03baB activation induces intestinal anti-inflammatory action of ginsenoside Rf in HT-29 and RAW264.7 cells","volume":"45","author":"Ahn","year":"2016","journal-title":"Immunological Investigations"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0025","series-title":"Roles of nitric oxide (no) and no synthases in healing of dextran sulfate sodium-induced rat colitis","author":"Aoi","year":"2008"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0030","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.3390\/molecules25225430","article-title":"Intestinal anti-inflammatory activity of terpenes in experimental models (2010\u22122020): A review","volume":"25","author":"Araruna","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10620-007-9863-8","article-title":"Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis","volume":"53","author":"Bai","year":"2008","journal-title":"Digestive Diseases and Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108456_bb0040","first-page":"4210","article-title":"Menthol inhibits oxidative stress and inflammation in acetic acid-induced colitis in rat colonic mucosa","volume":"10","author":"Bastaki","year":"2018","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0045","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s11010-021-04094-5","article-title":"Nerolidol, a sesquiterpene, attenuates oxidative stress and inflammation in acetic acid-induced colitis in rats","volume":"476","author":"Bastaki","year":"2021","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12324","article-title":"Effects of alpha-cyclodextrin on cholesterol control and compound K on glycaemic control in people with pre-diabetes: Protocol for a phase III randomized controlled trial","volume":"9","author":"Bessell","year":"2019","journal-title":"Clinical Obesity."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108456_bib840","first-page":"364","article-title":"Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis","volume":"37","author":"Burmester","year":"2020","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0055","article-title":"Treatment of inflammatory bowel disease: A comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00109-017-1557-x","article-title":"Layered defense: How mucus and tight junctions seal the intestinal barrier","volume":"95","author":"Capaldo","year":"2017","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0065","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/bcp.13589","article-title":"Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects: Oleuropein lowers postprandial glycaemia in healthy subjects","volume":"84","author":"Carnevale","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10787-019-00583-8","article-title":"Thymol reduces acetic acid-induced inflammatory response through inhibition of NF-kB signaling pathway in rat colon tissue","volume":"27","author":"Chamanara","year":"2019","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0075","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0080","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.3390\/molecules24193491","article-title":"Analysis of ginsenoside content (Panax ginseng) from different regions","volume":"24","author":"Chen","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113997","article-title":"Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3\/miR-214 signaling pathway","volume":"274","author":"Chen","year":"2021","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109512","article-title":"Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2\/HO-1 and NF-\u03baB pathways","volume":"344","author":"Chen","year":"2021","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cbi.2018.08.022","article-title":"Tussilagone, a major active component in Tussilago farfara, ameliorates inflammatory responses in dextran sulphate sodium-induced murine colitis","volume":"294","author":"Cheon","year":"2018","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.lfs.2006.11.038","article-title":"Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of \u03b2-caryophyllene, a sesquiterpene","volume":"80","author":"Cho","year":"2007","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lfs.2014.06.018","article-title":"Ursolic acid inhibits nuclear factor-\u03baB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice","volume":"110","author":"Chun","year":"2014","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cgh.2018.08.001","article-title":"AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: Expert review","volume":"17","author":"Colombel","year":"2019","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107194","article-title":"Improvement of magnesium isoglycyrrhizinate on DSS-induced acute and chronic colitis","volume":"90","author":"Cui","year":"2021","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.lfs.2013.04.013","article-title":"Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans","volume":"92","author":"d\u2019Alessio","year":"2013","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.dld.2005.03.013","article-title":"Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation","volume":"37","author":"Danese","year":"2005","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/md17020097","article-title":"Neorogioltriol and related diterpenes from the red alga laurencia inhibit inflammatory bowel disease in mice by suppressing M1 and promoting M2-like macrophage responses","volume":"17","author":"Daskalaki","year":"2019","journal-title":"Marine Drugs"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fphar.2020.00730","article-title":"Peroxisome proliferator-activated receptors: Experimental targeting for the treatment of inflammatory bowel diseases","volume":"11","author":"Decara","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bib839","doi-asserted-by":"crossref","unstructured":"D'Haens, G., Panaccione, R., Baert, F., Bossuyt, P., Colombel, J. F., Danese, S., Dubinsky, M., Feagan, B. G., Hisamatsu, T., Lim, A., Lindsay, J. O., Loftus, E. V., Jr, Pan\u00e9s, J., Peyrin-Biroulet, L., Ran, Z., Rubin, D. T., Sandborn, W. J., Schreiber, S., Neimark, E., Song, A., \u2026 Ferrante, M. (2022). Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Lancet (London, England), 399(10340), 2015\u20132030. https:\/\/doi.org\/10.1016\/S0140-6736(22)00467-6","DOI":"10.1016\/S0140-6736(22)00467-6"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0140","first-page":"116","article-title":"Microbiota in the gastrointestinal tract","volume":"6","author":"Dieterich","year":"2018","journal-title":"Medical Science"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027122","article-title":"Preventive and therapeutic euphol treatment attenuates experimental colitis in mice","volume":"6","author":"Dutra","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0150","article-title":"Use of rosemary extracts as a food additive - scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food","author":"EFSA","year":"2008","journal-title":"EFSA Journal"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103750","article-title":"Anti-inflammatory\/anti-apoptotic impact of betulin attenuates experimentally induced ulcerative colitis: An insight into TLR4\/NF-kB\/caspase signalling modulation","volume":"88","author":"El-Sherbiny","year":"2021","journal-title":"Environmental Toxicology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106144","article-title":"Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12, protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-\u03baB and NLRP3 inflammasome activation","volume":"80","author":"Fan","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0165","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.3390\/ijms24043957","article-title":"Cytokines in spondyloarthritis and inflammatory bowel diseases: From pathogenesis to therapeutic implications","volume":"24","author":"Felice","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10787-014-0203-2","article-title":"The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice","volume":"22","author":"Fitzpatrick","year":"2014","journal-title":"Inflammopharmacology."},{"issue":"10340","key":"10.1016\/j.pharmthera.2023.108456_bib841","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(22)00466-4","article-title":"Risankizumab as Maintenance Therapy for Moderately to Severely Active Crohn\u2019s Disease: Results from the Multicentre, Randomised, Double-Blind, Placebo-Controlled, Withdrawal Phase 3 FORTIFY Maintenance Trial","volume":"399","author":"Ferrante","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/jmf.2018.4271","article-title":"Pharmacokinetic study of compound K in Japanese subjects after ingestion of Panax ginseng fermented by lactobacillus paracasei A221 reveals significant increase of absorption into blood","volume":"22","author":"Fukami","year":"2019","journal-title":"Journal of Medicinal Food"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.intimp.2018.02.012","article-title":"Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Involvement of NF-\u03baB and MAPK signalling pathways","volume":"57","author":"Gao","year":"2018","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.116.234096","article-title":"Pregnane X receptor activation attenuates inflammation-associated intestinal epithelial barrier dysfunction by inhibiting cytokine-induced myosin light-chain kinase expression and c-Jun N-terminal kinase 1\/2 activation","volume":"359","author":"Garg","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2017.03.003","article-title":"The effect of menthol on acute experimental colitis in rats","volume":"805","author":"Ghasemi-Pirbaluti","year":"2017","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0195","doi-asserted-by":"crossref","first-page":"12882","DOI":"10.1021\/jf203715m","article-title":"Oleuropein ameliorates acute colitis in mice","volume":"59","author":"Giner","year":"2011","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2016.02.036","article-title":"Nerol alleviates pathologic markers in the oxazolone-induced colitis model","volume":"776","author":"Gonz\u00e1lez-Ram\u00edrez","year":"2016","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0205","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1074\/jbc.M809042200","article-title":"Tumor necrosis factor-\u03b1 induces caspase-mediated cleavage of peroxisome proliferator-activated receptor \u03b3 in adipocytes","volume":"284","author":"Guilherme","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0210","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bcp.2019.03.019","article-title":"Andrographolide derivative ameliorates dextran sulfate sodium-induced experimental colitis in mice","volume":"163","author":"Guo","year":"2019","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/08820139.2017.1322101","article-title":"Pregnane X receptor polymorphisms and risk of inflammatory bowel disease: A Meta-analysis","volume":"46","author":"Guo","year":"2017","journal-title":"Immunological Investigations"},{"issue":"9317","key":"10.1016\/j.pharmthera.2023.108456_bib850","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"ACCENT I Study Group. Maintenance Infliximab for Crohn\u2019s Disease: The ACCENT I Randomised Trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000527422","article-title":"New and emerging treatments for inflammatory bowel disease","volume":"104","author":"Higashiyama","year":"2023","journal-title":"Digestion."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0225","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119515","article-title":"Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis","volume":"586","author":"Huguet-Casquero","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0955-0674(00)00199-X","article-title":"The stat family in cytokine signaling","volume":"13","author":"Ihle","year":"2001","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108456_bib849","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/CEG.S367086","article-title":"Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes","volume":"16","author":"Irani","year":"2023","journal-title":"Clinical and Experimental Gastroenterology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1248\/bpb.b21-00658","article-title":"Impact of gut microbiota on the pharmacokinetics of Glycyrrhizic acid in Yokukansan, a Kampo medicine","volume":"45","author":"Ishida","year":"2022","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0245","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1021\/jf501487v","article-title":"Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 on macrophages","volume":"62","author":"Jang","year":"2014","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0250","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/molecules21040523","article-title":"Glycyrrhetic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in vivo","volume":"21","author":"Jeon","year":"2016","journal-title":"Molecules."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106576","article-title":"Anti-inflammatory activity of phenylpropyl triterpenoids from Osmanthus fragrans var. aurantiacus leaves","volume":"86","author":"Jeong","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117164","article-title":"Andrographolide derivative AL-1 reduces intestinal permeability in dextran sulfate sodium (DSS)-induced mice colitis model","volume":"241","author":"Jiang","year":"2020","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0265","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.ejmech.2008.12.014","article-title":"Synthesis and evaluation of antibacterial activities of andrographolide analogues","volume":"44","author":"Jiang","year":"2009","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6138723","article-title":"Andrographolide derivative AL-1 ameliorates dextran sodium sulfate-induced murine colitis by inhibiting NF- \u03ba B and MAPK signaling pathways","volume":"2019","author":"Jing","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103632","article-title":"Serratane triterpenoids isolated from Lycopodium clavatum by bioactivity-guided fractionation attenuate the production of inflammatory mediators","volume":"96","author":"Jo","year":"2020","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0280","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1476-5381.2010.01195.x","article-title":"Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-\u03baB and MAPK pathways: Kalopanaxsaponin a inhibits IRAK-1 activation","volume":"162","author":"Joh","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0285","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bcp.2011.05.003","article-title":"Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation\u2014The key step of inflammation","volume":"82","author":"Joh","year":"2011","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108456_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14712\/fb2008054010001","article-title":"Effects of borneol and thymoquinone on TNBS-induced colitis in mice","volume":"54","author":"Juh\u00e1s","year":"2008","journal-title":"Folia Biologica"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12272-010-2230-x","article-title":"Attenuation of experimental murine colitis by Acanthoic acid from Acanthopanax koreanum","volume":"33","author":"Kang","year":"2010","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0305","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/MIB.0000000000000468","article-title":"A multihit model: Colitis lessons from the interleukin-10\u2013deficient mouse","volume":"21","author":"Keubler","year":"2015","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0310","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0315","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.3390\/molecules26144326","article-title":"Diterpenoids isolated from podocarpus macrophyllus inhibited the inflammatory mediators in LPS-induced HT-29 and RAW 264.7 cells","volume":"26","author":"Kim","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0320","series-title":"Medication routes of administration, in: StatPearls","author":"Kim","year":"2023"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cccn.2004.01.004","article-title":"Acanthoic acid inhibits IL-8 production via MAPKs and NF-kappaB in a TNF-alpha-stimulated human intestinal epithelial cell line","volume":"342","author":"Kim","year":"2004","journal-title":"Clinica Chimica Acta: International Journal of Clinical Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113646","article-title":"Andrographolide inhibits inflammatory responses in LPS-stimulated macrophages and murine acute colitis through activating AMPK","volume":"170","author":"Kim","year":"2019","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00054725-200409000-00010","article-title":"Catalposide, a compound isolated from catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice","volume":"10","author":"Kim","year":"2004","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0340","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/nu9040391","article-title":"Oleuropein decreases cyclooxygenase-2 and interleukin-17 expression and attenuates inflammatory damage in colonic samples from ulcerative colitis patients","volume":"9","author":"Larussa","year":"2017","journal-title":"Nutrients."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0345","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lfs.2016.01.001","article-title":"Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis","volume":"146","author":"Lee","year":"2016","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0350","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1021\/jf301372g","article-title":"Ginsenoside re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages","volume":"60","author":"Lee","year":"2012","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0355","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1248\/bpb.b16-00895","article-title":"Triterpenoids isolated from Alnus japonica inhibited LPS-induced inflammatory mediators in HT-29 cells and RAW264.7 cells","volume":"40","author":"Lee","year":"2017","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0360","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejphar.2015.06.011","article-title":"Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis","volume":"762","author":"Lee","year":"2015","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0365","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10620-012-2495-7","article-title":"Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis","volume":"58","author":"Lee","year":"2013","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0370","doi-asserted-by":"crossref","first-page":"S725","DOI":"10.1093\/ecco-jcc\/jjaa014","article-title":"Clinical pharmacology of Janus kinase inhibitors in inflammatory bowel disease","volume":"14","author":"Lefevre","year":"2020","journal-title":"Journal of Crohn\u2019s & Colitis"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0375","article-title":"Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-\u03baB activation","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106288","article-title":"Saikosaponin-d ameliorates dextran sulfate sodium-induced colitis by suppressing NF-\u03baB activation and modulating the gut microbiota in mice","volume":"81","author":"Li","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0385","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.molimm.2010.06.007","article-title":"Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6\/STAT3 signaling pathway and down-regulation of IL-17","volume":"47","author":"Li","year":"2010","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0390","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10787-019-00639-9","article-title":"Genipin attenuates dextran sulfate sodium-induced colitis via suppressing inflammatory and oxidative responses","volume":"28","author":"Li","year":"2020","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0395","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3892\/mmr.2016.5094","article-title":"Ursolic acid protects against ulcerative colitis via anti-inflammatory and antioxidant effects in mice","volume":"13","author":"Liu","year":"2016","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0400","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/MIB.0000000000000439","article-title":"Anti-inflammatory effects of ganoderma lucidum triterpenoid in human crohn\u02bcs disease associated with downregulation of NF-\u03baB signaling","volume":"21","author":"Liu","year":"2015","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105768","article-title":"Limonin ameliorates ulcerative colitis by regulating STAT3\/miR-214 signaling pathway","volume":"75","author":"Liu","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0410","doi-asserted-by":"crossref","first-page":"1045901","DOI":"10.3389\/fimmu.2022.1045901","article-title":"Cassane diterpenoid ameliorates dextran sulfate sodium-induced experimental colitis by regulating gut microbiota and suppressing tryptophan metabolism","volume":"13","author":"Liu","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0415","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0420","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.2042-7158.2010.01185.x","article-title":"Protective effects of glycyrrhizic acid by rectal treatment on a TNBS-induced rat colitis model","volume":"63","author":"Liu","year":"2011","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108456_bib851","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/apt.16060","article-title":"Long-Term Safety of Vedolizumab for Inflammatory Bowel Disease","volume":"52","author":"Loftus","year":"2020","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0425","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1023\/B:DDAS.0000037822.55717.31","article-title":"Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease","volume":"49","author":"Magro","year":"2004","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105075","article-title":"Inflammatory bowel disease \u2013 Non-biological treatment","volume":"160","author":"Magro","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0435","first-page":"755","article-title":"Is tofacitinib a game-changing drug for ulcerative colitis?, united Eur","volume":"8","author":"Magro","year":"2020","journal-title":"Gastroenterologisches Journal"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0440","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jgh.14872","article-title":"The epidemiology of inflammatory bowel disease: East meets west","volume":"35","author":"Mak","year":"2020","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0445","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2893.2011.01579.x","article-title":"The European SNMC study group, glycyrrhizin in patients who failed previous interferon alpha-based therapies: Biochemical and histological effects after 52 weeks","volume":"19","author":"Manns","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0450","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3389\/fimmu.2018.02566","article-title":"The role of NLRP3 and IL-1\u03b2 in the pathogenesis of inflammatory bowel disease","volume":"9","author":"Mao","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0455","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2796.2012.02588.x","article-title":"Targeting T-cell migration in inflammatory bowel disease","volume":"272","author":"Marsal","year":"2012","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108941","article-title":"Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease","volume":"709","author":"Mas-Bargues","year":"2021","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0465","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.molimm.2013.01.018","article-title":"Preventive and therapeutic oral administration of the pentacyclic triterpene \u03b1,\u03b2-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system","volume":"54","author":"Matos","year":"2013","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0470","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1039\/C5FO00405E","article-title":"Oral administration of geraniol ameliorates acute experimental murine colitis by inhibiting pro-inflammatory cytokines and NF-\u03baB signaling","volume":"6","author":"Medicherla","year":"2015","journal-title":"Food & Function"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0475","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JIR.S277457","article-title":"Role of Caspase-1 in the pathogenesis of inflammatory-associated chronic noncommunicable diseases","volume":"13","author":"Molla","year":"2020","journal-title":"Journal of Inflammation Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0480","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.foodchem.2013.01.101","article-title":"Influence of triterpenoids present in apple peel on inflammatory gene expression associated with inflammatory bowel disease (IBD)","volume":"139","author":"Mueller","year":"2013","journal-title":"Food Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0485","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1440-1746.2003.03034.x","article-title":"Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice","volume":"18","author":"Naito","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0490","series-title":"Mesalamine (USAN), in: StatPearls","author":"Nakashima","year":"2023"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0495","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0500","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.3390\/ijms22115710","article-title":"Biochemistry of terpenes and recent advances in plant protection","volume":"22","author":"Ninkuu","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0505","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.intimp.2016.07.003","article-title":"Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in mice","volume":"39","author":"Niu","year":"2016","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0510","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20090849","article-title":"TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis","volume":"207","author":"Noti","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0515","first-page":"1","article-title":"Cell death and inflammatory bowel diseases: Apoptosis, necrosis, and autophagy in the intestinal epithelium","volume":"2014","author":"Nunes","year":"2014","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108456_bib842","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcmgh.2017.03.010","article-title":"Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor","volume":"4","author":"Oh-oka","year":"2017","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0520","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3390\/cells9122629","article-title":"Extracellular matrix mechanical properties and regulation of the intestinal stem cells: When mechanics control fate","volume":"9","author":"Onfroy-Roy","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0525","doi-asserted-by":"crossref","first-page":"1700751","DOI":"10.1002\/mnfr.201700751","article-title":"Bioavailability of terpenes and postprandial effect on human antioxidant potential. An open-label study in healthy subjects","volume":"62","author":"Papada","year":"2018","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0530","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbrc.2004.07.186","article-title":"Celastrol inhibits pro-inflammatory cytokine secretion in Crohn\u2019s disease biopsies","volume":"322","author":"Pinna","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105243","article-title":"The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases","volume":"163","author":"Piotrowska","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0540","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: Inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0545","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4196\/kjpp.2014.18.4.279","article-title":"A review on chemical-induced inflammatory bowel disease models in rodents","volume":"18","author":"Randhawa","year":"2014","journal-title":"The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0550","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.201902040R","article-title":"Plumericin prevents intestinal inflammation and oxidative stress in vitro and in vivo","volume":"34","author":"Rapa","year":"2020","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0555","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.1038\/s41598-019-53305-z","article-title":"Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-\u03baB signaling pathway","volume":"9","author":"Ren","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0560","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/mnfr.201300052","article-title":"Bioavailability of the major bioactive diterpenoids in a rosemary extract: Metabolic profile in the intestine, liver, plasma, and brain of Zucker rats","volume":"57","author":"Romo Vaquero","year":"2013","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0565","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/ijms20081887","article-title":"Tumour necrosis factor alpha in intestinal homeostasis and gut related diseases","volume":"20","author":"Ruder","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0570","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/eji.200737744","article-title":"Toll-like receptors\u2019 two-edged sword: When immunity meets apoptosis","volume":"37","author":"Salaun","year":"2007","journal-title":"European Journal of Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108456_bib848","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1053\/j.gastro.2020.02.030","article-title":"Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108456_bib844","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ibd\/izaa236","article-title":"Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2\/3 Studies","volume":"27","author":"Sandborn","year":"2021","journal-title":"Inflammatory Bowel Diseases"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108456_bib843","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","article-title":"Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"385","author":"Sandborn","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108456_bib846","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/apt.16712","article-title":"Safety and Efficacy of Tofacitinib for Treatment of Ulcerative Colitis: Final Analysis of OCTAVE Open, an Open-Label, Long-Term Extension Study with up to 7.0 Years of Treatment","volume":"55","author":"Sandborn","year":"2022","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108456_bib838","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cgh.2021.02.025","article-title":"Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn\u2019s Disease: The IM-UNITI Trial","volume":"20","author":"Sandborn","year":"2022","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0575","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41422-020-0301-1","article-title":"Signaling networks in immunometabolism","volume":"30","author":"Saravia","year":"2020","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0580","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/ptr.5657","article-title":"Nimbolide inhibits nuclear factor-\u041aB pathway in intestinal epithelial cells and macrophages and alleviates experimental colitis in mice: Antiinflammatory effect of nimbolide in experimental colitis","volume":"30","author":"Seo","year":"2016","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0585","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10787-014-0226-8","article-title":"Modulation of PPAR\u03b3 and TNF\u03b1 by emu oil and glycyrrhizin in ulcerative colitis","volume":"23","author":"Sethuraman","year":"2015","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0590","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2013.12.007","article-title":"Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis","volume":"210","author":"Shaker","year":"2014","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0595","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.3390\/ijms21186963","article-title":"Sudachinoid- and Ichangensin-type Limonoids from Citrus junos downregulate pro-inflammatory cytokines","volume":"21","author":"Shin","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0600","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.fct.2012.12.013","article-title":"Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-\u03baB inactivation","volume":"53","author":"Shin","year":"2013","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0605","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.MIB.0000436467.37566.48","article-title":"Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD","volume":"20","author":"Song","year":"2014","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0610","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.lfs.2015.07.004","article-title":"Geraniol ameliorates TNBS-induced colitis: Involvement of Wnt\/\u03b2-catenin, p38MAPK, NF\u03baB, and PPAR\u03b3 signaling pathways","volume":"136","author":"Soubh","year":"2015","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0615","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.intimp.2009.08.017","article-title":"Si-Ni-san, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance","volume":"9","author":"Sun","year":"2009","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0620","series-title":"Thymol has beneficial effects on the experimental model of ulcerative colitis","volume":"9","author":"Tahmasebi","year":"2019"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00425-018-3056-x","article-title":"Terpenes and isoprenoids: A wealth of compounds for global use","volume":"249","author":"Tetali","year":"2019","journal-title":"Planta."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107491","article-title":"Pristimerin reduces dextran sulfate sodium-induced colitis in mice by inhibiting microRNA-155","volume":"94","author":"Tian","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108456_bb0635","first-page":"210","article-title":"Herbal and plant therapy in patients with inflammatory bowel disease","volume":"28","author":"Triantafyllidi","year":"2015","journal-title":"Annals of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0640","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1021\/acs.jafc.8b00353","article-title":"Intestinal anti-inflammatory activity of perillaldehyde","volume":"66","author":"Uemura","year":"2018","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0645","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/nu13030773","article-title":"Pharmacokinetic analysis of carnosic acid and carnosol in standardized rosemary extract and the effect on the disease activity index of DSS-induced colitis","volume":"13","author":"Veenstra","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115729","article-title":"Pharmacokinetic characterization of carnosol from rosemary (Salvia Rosmarinus) in male C57BL\/6 mice and inhibition profile in human cytochrome P450 enzymes","volume":"431","author":"Vemu","year":"2021","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0655","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.3390\/ijms24076160","article-title":"Molecular docking identifies 1,8-cineole (eucalyptol) as a novel PPAR\u03b3 agonist that alleviates colon inflammation","volume":"24","author":"Venkataraman","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0660","article-title":"Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, a- and b-amyrin, in a mouse model of colitis","volume":"11","author":"Vitor","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0665","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12876-020-01229-8","article-title":"Serum amyloid a is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission","volume":"20","author":"Wakai","year":"2020","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0670","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3851","article-title":"Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota: Enteric metabolites of American ginseng","volume":"31","author":"Wan","year":"2017","journal-title":"Biomedical Chromatography"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0675","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/kjm2.12160","article-title":"Loganin alleviates LPS-activated intestinal epithelial inflammation by regulating TLR4\/NF-\u03baB and JAK\/STAT3 signaling pathways","volume":"36","author":"Wang","year":"2020","journal-title":"The Kaohsiung Journal of Medical Sciences"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0680","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1038\/srep12845","article-title":"Diterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O-acetylneoline in a murine model of ulcerative colitis","volume":"5","author":"Wangchuk","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0685","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.intimp.2008.08.019","article-title":"Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis","volume":"8","author":"Wei","year":"2008","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0690","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0695","first-page":"1","article-title":"A protective role of the NRF2-Keap1 pathway in maintaining intestinal barrier function","volume":"2019","author":"Wen","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0700","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acs.biomac.1c01233","article-title":"Preparation of oral core\u2013shell zein nanoparticles to improve the bioavailability of glycyrrhizic acid for the treatment of ulcerative colitis","volume":"23","author":"Wu","year":"2022","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0705","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.ATV.0000157899.35660.61","article-title":"Transcriptional control of COX-2 via C\/EBP\u03b2","volume":"25","author":"Wu","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0710","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2019.7907","article-title":"Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo","author":"Wu","year":"2019","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0715","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s10753-019-01085-z","article-title":"Paeoniflorin prevents intestinal barrier disruption and inhibits lipopolysaccharide (LPS)-induced inflammation in Caco-2 cell monolayers","volume":"42","author":"Wu","year":"2019","journal-title":"Inflammation."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0720","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15905","article-title":"Efficacy of diammonium glycyrrhizinate in the treatment of rosacea with papules and pustules: A randomized, double-blind, placebo-controlled study","volume":"35","author":"Xie","year":"2022","journal-title":"Dermatologic Therapy"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0725","doi-asserted-by":"crossref","first-page":"G535","DOI":"10.1152\/ajpgi.00385.2006","article-title":"Characterization of the human intestinal CD98 promoter and its regulation by interferon-\u03b3","volume":"292","author":"Yan","year":"2007","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0730","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11655-012-1173-0","article-title":"A randomized controlled trial comparing total glucosides of paeony capsule and compound glycyrrhizin tablet for alopecia areata","volume":"18","author":"Yang","year":"2012","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0735","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1038\/s41598-017-11408-5","article-title":"Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1\/Nrf2 pathway","volume":"7","author":"Yang","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0740","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s12272-012-0714-6","article-title":"Therapeutic effect of ginsenoside Rd in rats with TNBS-induced recurrent ulcerative colitis","volume":"35","author":"Yang","year":"2012","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0745","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.intimp.2011.12.014","article-title":"Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis","volume":"12","author":"Yang","year":"2012","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0750","doi-asserted-by":"crossref","first-page":"29716","DOI":"10.1038\/srep29716","article-title":"Andrographolide derivative AL-1 ameliorates TNBS-induced colitis in mice: Involvement of NF-\u043aB and PPAR-\u03b3 signaling pathways","volume":"6","author":"Yang","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0755","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ecco-jcc\/jjz176","article-title":"Deletion of IL-6 exacerbates colitis and induces systemic inflammation in IL-10-deficient mice","volume":"14","author":"Ye","year":"2020","journal-title":"Journal of Crohn\u2019s & Colitis"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0760","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.fitote.2011.02.011","article-title":"Triptolide ameliorates Crohn\u2019s colitis is associated with inhibition of TLRs\/NF-\u03baB signaling pathway","volume":"82","author":"Yu","year":"2011","journal-title":"Fitoterapia."},{"key":"10.1016\/j.pharmthera.2023.108456_bb0765","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3892\/mmr.2017.6241","article-title":"D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways","volume":"15","author":"Yu","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0770","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.3748\/wjg.v12.i28.4578","article-title":"Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis","volume":"12","author":"Yuan","year":"2006","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106240","article-title":"Protective effects of iridoid glycosides on acute colitis via inhibition of the inflammatory response mediated by the STAT3\/NF-\u043aB pathway","volume":"81","author":"Yuan","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0780","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/dmd.115.063800","article-title":"Ginsenosides regulate PXR\/NF- \u03ba B signaling and attenuate dextran sulfate sodium\u2013induced colitis","volume":"43","author":"Zhang","year":"2015","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0785","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.114.218750","article-title":"Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation","volume":"352","author":"Zhang","year":"2015","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0790","doi-asserted-by":"crossref","first-page":"G27","DOI":"10.1152\/ajpgi.00465.2012","article-title":"Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway","volume":"306","author":"Zhang","year":"2014","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0795","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.2147\/DDDT.S79388","article-title":"Tanshinone IIA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor","author":"Zhang","year":"2015","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0800","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1021\/acs.jmedchem.9b01865","article-title":"Emerging substrate proteins of kelch-like ECH associated protein 1 (Keap1) and potential challenges for the development of small-molecule inhibitors of the Keap1-nuclear factor erythroid 2-related factor 2 (Nrf2) protein\u2013protein interaction","volume":"63","author":"Zhang","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0805","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.intimp.2017.05.033","article-title":"Administration of geniposide ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of inflammation and mucosal damage","volume":"49","author":"Zhang","year":"2017","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0810","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.intimp.2015.03.033","article-title":"Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy","volume":"26","author":"Zhao","year":"2015","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0815","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.intimp.2011.11.007","article-title":"Parthenolide, an inhibitor of the nuclear factor-\u03baB pathway, ameliorates dextran sulfate sodium-induced colitis in mice","volume":"12","author":"Zhao","year":"2012","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0820","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.intimp.2019.04.024","article-title":"Saikosaponin a protects against dextran sulfate sodium-induced colitis in mice","volume":"72","author":"Zhou","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0825","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10717544.2017.1384521","article-title":"Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice","volume":"24","author":"Zhou","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5659738","article-title":"The possible anti-inflammatory effect of dehydrocostus lactone on DSS-induced colitis in mice","volume":"2020","author":"Zhou","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2023.108456_bb0835","series-title":"Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23\/IL-17 axis","first-page":"11","author":"Zhu","year":"2018"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:31:15Z","timestamp":1759012275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":180,"alternative-id":["S0163725823001201"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108456","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108456"}}